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In the development of new pharmaceutical formulation strategies, the need for 
innovative drug particle size reduction approaches has significantly increased during 
the past decades. In the US poorly soluble compounds represent 40% of the top 200 
marketed oral drugs and 33% of the drugs listed in the US Pharmacopeia. Additionally, 
75% of compounds under development and 90% of new chemical entities are poorly 
soluble [Rodriguez 2015]. A frequently used method to improve the dissolution rate and 
transport characteristics of these drugs is particle size reduction. Thereby faster 
absorption and more effective cellular uptake can be achieved [Mosharraf 1995, 
Rasenack 2003]. 
Since pulsed laser ablation is a well-established technique for particle generation 
from both inorganic and organic materials, pharmaceutically relevant investigations 
became interested in using laser ablation as a particle size reduction technique 
[Sylvestre 2011, Ding 2014, Hopp 2018, Singh 2020, Gera 2020]. In this systematic study 
we demonstrate the application of pulsed laser ablation for the fragmentation of drug 





Pulsed laser ablation in liquid (PLAL) was used to generate particles from meloxicam 
(mx.), a medically relevant poorly water-soluble nonsteroidal anti-inflammatory drug 
(NSAID). As targets, pastilles were pressed from commercially available meloxicam 
powder (EGIS Ltd, Budapest, Hungary) by a hydraulic compactor at 175 MPa pressure. 
To determine the suitable parameter range for ablation, nanosecond (ns) laser pulses of 
different wavelengths (248 nm, 532 nm and 1064 nm) and fluences (~ 3-13 J/cm2) were 
investigated in distilled water environment [Nagy 2019]. 
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To characterize the generated particles several methods were applied. Fourier 
transform infrared spectroscopy (FTIR) was used for chemical analysis. The size-
distribution and morphology of the generated particles were studied by scanning 
electron microscopy (SEM). The crystallinity was investigated by X-ray powder 
diffraction (XRPD). Heat induced phase transitions of the PLAL generated particles were 
detected by differential scanning calorimetry (DSC) [Hopp 2018]. 
The ablation dynamics were studied using the time-resolved pump-probe 
shadowgraphy technique. Fast photography took place with a nanosecond time 
resolution. The ablation process was investigated at three different fluences using 
532 nm laser wavelength. 
 
 
3. RESULTS AND DISCUSSION 
 
3.1. Characterization of the generated particles 
 
The FTIR spectra of PLAL produced particles match the spectra of the original 
meloxicam powder in the investigated fluence range at all applied wavelengths 
(Figure 1.). The presence of the characteristic peaks indicates that chemically identical 
meloxicam particles can be generated from a drug pastille by PLAL [Hopp 2018, 
Nagy 2019]. 




















Figure 1. FTIR spectra of PLAL generated meloxicam particles (F= 9.4 J/cm2)  
and reference meloxicam (mx.) powder. 
 
SEM images revealed significant reduction in the size of the meloxicam particles as 
compared to the commercially available reference meloxicam powder. The morphology 
of the PLAL generated particles resembled broken pieces, scattered crystals, indicating 
that mechanical effects could have been the most relevant factors during fragmentation 





Figure 2. SEM images of the original meloxicam powder particles and of the particles obtained from the 
meloxicam suspensions produced at different wavelengths (Mag.: 1000x, scale 50.0 µm) 
The 532 nm laser wavelength provided the highest ablation yield. Size-
distributions were determined using ImageJ® image processing and analysis software 
[Hopp 2018, Nagy 2019]. 
In case of the PLAL generated particles XRDP characterization showed slight 
decrease (∼ 7%) in the crystallinity and DSC investigations showed an approximately 20 
°C shift to the lower temperatures in the melting point compared to the commercially 
available meloxicam powder. Both of these measurements indicate that PLAL causes the 
amorphization of meloxicam to some degree [Hopp 2018]. 
 
3.2. Characterization of the ablation process 
 
Based on the time-resolved fast photography observations, three main parts of the 
ablation process can be distinguished (Figure 3.). In the first few hundred nanoseconds 
the refractive index of the medium changes and numerous small bubbles appear. 
Evaluating the recorded sequence of pictures, the formation and propagation of the 
wavefront was constructed. The velocity of the wave propagation was found to be 1480 
m/s, which is the velocity of sound in water. This means, that the shockwaves slow 
down very quickly (after a few 10 ns) and become acoustic waves. The second part, 
between a few and a few hundred microseconds, is the time period when the formation 
and pulsation of the cavitation bubble takes place. The third part, a few milliseconds 
after the laser pulse, is when the cavitation bubble collapses and the ablated particles 
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Figure 3. Time-resolved fast photography pictures. The sequence of the pulsed laser ablation (λ=532 nm, 
F = 6 J/cm2) of a meloxicam pastille. Ablation process as discussed in the text: part one: A)-C), part two: 





PLAL proved to be a non-damaging, clean (chemical free) and effective way of 
generating few micrometre and sub-micrometre sized meloxicam particles. The size of 
PLAL produced particles was around one-tenth of the average size of the commercially 
available meloxicam powder particles and comparable with the size of particles 
produced by conventional techniques (grinding, wet milling). Time-resolved fast 
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